Spots Global Cancer Trial Database for magnetic resonance elastography
Every month we try and update this database with for magnetic resonance elastography cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Measuring Brain Tumor Consistency Using Magnetic Resonance Elastography | NCT05516485 | Brain Neoplasm | Assessment Magnetic Resona... | 18 Years - | University of Southern California | |
| Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion | NCT05990244 | Glioma | Magnetic Resona... Assessment and ... | 18 Years - 80 Years | Shengjing Hospital | |
| Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease | NCT00543777 | Liver Cancer | Magnetic Resona... 2-Point Dixon M... | - | M.D. Anderson Cancer Center | |
| MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment | NCT05957679 | Spinal Cord Tum... | Magnetic Resona... Assessment and ... | 18 Years - 80 Years | Shengjing Hospital | |
| Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) | NCT01447667 | Hepatic Fibrosi... Hepatocellular ... | Magnetic resona... | 18 Years - 80 Years | Seoul National University Hospital | |
| Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer | NCT03831932 | Advanced Lung N... Metastatic Lung... Stage IV Lung C... | Biospecimen Col... Computed Tomogr... Magnetic Resona... Osimertinib Positron Emissi... Telaglenastat H... X-Ray Imaging | 18 Years - | National Cancer Institute (NCI) | |
| MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment | NCT05957679 | Spinal Cord Tum... | Magnetic Resona... Assessment and ... | 18 Years - 80 Years | Shengjing Hospital | |
| Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion | NCT05990244 | Glioma | Magnetic Resona... Assessment and ... | 18 Years - 80 Years | Shengjing Hospital | |
| An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer | NCT04022746 | Advanced Adult ... Stage III Hepat... Stage IIIA Hepa... Stage IIIB Hepa... Stage IV Hepato... Stage IVA Hepat... Stage IVB Hepat... | Magnetic Resona... Magnetic Resona... | 18 Years - | M.D. Anderson Cancer Center | |
| A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma | NCT02339571 | Stage III Cutan... Stage IV Cutane... | Biospecimen Col... Computed Tomogr... Echocardiograph... Ipilimumab Magnetic Resona... Multigated Acqu... Nivolumab Sargramostim | 18 Years - | National Cancer Institute (NCI) | |
| Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer | NCT05840770 | Metastatic Lung... Metastatic Mali... Stage IV Lung C... | Biospecimen Col... Cemiplimab Computed Tomogr... Magnetic Resona... Positron Emissi... | 18 Years - | City of Hope Medical Center | |
| Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer | NCT02298959 | Clinical Stage ... Metastatic Colo... Metastatic Mali... Metastatic Mela... Metastatic Ovar... Metastatic Rena... Platinum-Resist... Recurrent Melan... Recurrent Renal... Refractory Mela... Refractory Rena... Sarcoma Stage IV Colore... Stage IV Ovaria... Stage IV Renal ... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Pembrolizumab Ziv-Aflibercept | 18 Years - | National Cancer Institute (NCI) | |
| MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas | NCT04373720 | Glioma | Magnetic Resona... Magnetic Resona... | 18 Years - | M.D. Anderson Cancer Center | |
| Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer | NCT05840770 | Metastatic Lung... Metastatic Mali... Stage IV Lung C... | Biospecimen Col... Cemiplimab Computed Tomogr... Magnetic Resona... Positron Emissi... | 18 Years - | City of Hope Medical Center | |
| Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease | NCT00543777 | Liver Cancer | Magnetic Resona... 2-Point Dixon M... | - | M.D. Anderson Cancer Center | |
| MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases | NCT06208397 | Metastatic Colo... | Magnetic Resona... | 18 Years - 80 Years | Shengjing Hospital | |
| Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) | NCT01447667 | Hepatic Fibrosi... Hepatocellular ... | Magnetic resona... | 18 Years - 80 Years | Seoul National University Hospital | |
| Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer | NCT02298959 | Clinical Stage ... Metastatic Colo... Metastatic Mali... Metastatic Mela... Metastatic Ovar... Metastatic Rena... Platinum-Resist... Recurrent Melan... Recurrent Renal... Refractory Mela... Refractory Rena... Sarcoma Stage IV Colore... Stage IV Ovaria... Stage IV Renal ... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Pembrolizumab Ziv-Aflibercept | 18 Years - | National Cancer Institute (NCI) | |
| Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer | NCT02298959 | Clinical Stage ... Metastatic Colo... Metastatic Mali... Metastatic Mela... Metastatic Ovar... Metastatic Rena... Platinum-Resist... Recurrent Melan... Recurrent Renal... Refractory Mela... Refractory Rena... Sarcoma Stage IV Colore... Stage IV Ovaria... Stage IV Renal ... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Pembrolizumab Ziv-Aflibercept | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
